Media Centre
2018
November 2018
3 – 7 Neuroscience 2018, San Diego
5 – 7 BIO-Europe, Copenhagen
14 – 15 Jefferies 2018 Healthcare Conference, London
October 2018
4 – 5 Sachs 18th Annual Biotech in Europe Forum, Basel
August 2018
20 – 22 The 2nd Annual IPF Summit 2018, San Francisco
June 2018
3 – 6 The Ubiquitin System: Function, Physiology and its Role in Disease, Nassau
May 2018
9– 11 Mitochondrial Medicine 2018, Cambridge
14 – 16 Bio€quity Europe, Ghent
23 – 24 UK CEO and Investor Forum 2018, Buckinghamshire
April 2018
11 BIA Networking Breakfast, London
18 – 19 4th UK Autophagy Network Meeting, Cambridge
23 – 24 BioTrinity, London
February 2018
22 – 23 Enzymes in Drug Discovery Summit, San Diego
26 – 27 Sachs 11th Annual European Life Sciences CEO Forum & Exhibition, Zurich
January 2018
8 – 11 J.P.Morgan Annual Healthcare Conference, San Francisco
28 – 1 Keystone Ubiquitin 2018, Tahoe City
30 – 1 Synthetic Lethality Summit 2018, Boston
Get in touch
MISSION THERAPEUTICS
The Glenn Berge Building
Babraham Research Campus
Babraham
Cambridge
CB22 3FH
United Kingdom
T: +44 (0)1223 607 340
E: info@missiontherapeutics.com
Latest news
- Mission Therapeutics authorised to initiate first clinical trial for lead DUB program, MTX652, in kidney disease31st March 2022
- Mission Therapeutics to Participate in SVB Leerink Biopharma Private Company Connect Event25th March 2022
- Mission Therapeutics to participate in BIO-Europe Spring 202222nd March 2022